SF
WST icon

Synovus Financial’s West Pharmaceutical WST Stock Holding History

Synovus Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$343K Hold
1,307
– – ﹤0.01% 779
2025
Q2 		$286K Sell
1,307
-23
-2% -$4.92K ﹤0.01% 791
2025
Q1 		$298K Hold
1,330
– – ﹤0.01% 769
2024
Q4 		$436K Sell
1,330
-77
-5% -$24.2K 0.01% 676
2024
Q3 		$422K Sell
1,407
-65
-4% -$19.9K ﹤0.01% 723
2024
Q2 		$485K Sell
1,472
-71
-5% -$25.1K 0.01% 622
2024
Q1 		$611K Buy
+1,543
New +$571K 0.01% 579
2022
Q3 		– Sell
-1,521
Closed -$466K – 887
2022
Q2 		$466K Buy
1,521
+88
+6% +$28.6K 0.01% 600
2022
Q1 		$589K Sell
1,433
-62
-4% -$24.3K 0.01% 578
2021
Q4 		$695K Buy
1,495
+28
+2% +$12.1K 0.01% 547
2021
Q3 		$620K Sell
1,467
-658
-31% -$277K 0.01% 560
2021
Q2 		$763K Buy
+2,125
New +$702K 0.01% 503
2020
Q3 		– Sell
-55
Closed -$12K – 1470
2020
Q2 		$12K Sell
55
-733
-93% -$144K ﹤0.01% 1191
2020
Q1 		$120K Buy
788
+733
+1,333% +$113K ﹤0.01% 880
2019
Q4 		$8K Buy
55
+21
+62% +$3.06K ﹤0.01% 1253
2019
Q3 		$5K Hold
34
– – ﹤0.01% 1298
2019
Q2 		$4K Hold
34
– – ﹤0.01% 1266
2019
Q1 		$4K Hold
34
– – ﹤0.01% 1278
2018
Q4 		$3K Hold
34
– – ﹤0.01% 1288
2018
Q3 		$4K Buy
+34
New +$3.81K ﹤0.01% 1277
2015
Q2 		– Sell
-61
Closed -$4K – 1043
2015
Q1 		$4K Buy
61
+30
+97% +$1.6K ﹤0.01% 958
2014
Q4 		$2K Hold
31
– – ﹤0.01% 1006
2014
Q3 		$1K Buy
+31
New +$1.32K ﹤0.01% 960

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Synovus Financial's WST Position: Q3 2025 in Review

Synovus Financial held its West Pharmaceutical (WST) position steady in Q3 2025 at 1,307 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #779.

Synovus Financial first reported a position in WST in Q3 2014 and has held it in 23 quarters since. The position peaked at $763K in Q2 2021. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Synovus Financial held 1,307 shares of West Pharmaceutical worth $343K as of Q3 2025.
  • Synovus Financial left its West Pharmaceutical share count unchanged in Q3 2025.
  • West Pharmaceutical made up ﹤0.01% of Synovus Financial's portfolio in Q3 2025, its #779 holding.
  • Synovus Financial first reported a position in West Pharmaceutical in Q3 2014 and has held it in 23 quarters since.
  • Synovus Financial's West Pharmaceutical position peaked at $763K in Q2 2021.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.